OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
The figure missed the Zacks Consensus Estimate of a loss of 9 cents per share by 33.3%. Revenues in Detail OPKO Health registered sales of $173.7 million, down 26.9% year over year. The figure missed the Zacks Consensus Estimate by 5%. Lower revenues from the transfer of intellectual property and others dragged the overall top line. Segmental Revenues OPKO Health manages its operations through two reportable segments, Diagnostics and Pharmaceuticals. Within the Diagnostics arm, revenues from services amounted to $126.9 million, down 4.2% year over year, primarily resulting from lower clinical test volume. This compares with our projection of $126.1 million from services revenues. The company entered into an agreement with Labcorp earlier this year to divest select assets of BioReference Health, which includes laboratory testing businesses focused on clinical diagnostics and women's health for $237.5 million. The transaction is expected to close in the second half of 2024
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Komodo Grows Its MapEnhance Offering, Expanding Access to New Social Determinants of Health Insights Alongside Real-World Oncology Data and Rare Disease Genomics [Yahoo! Finance]Yahoo! Finance
- Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates [Yahoo! Finance]Yahoo! Finance
- OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
OPK
Earnings
- 5/7/24 - Miss
OPK
Sec Filings
- 5/17/24 - Form 4
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- OPK's page on the SEC website